GeoVax Labs, Inc. — Form S-1
Filed September 17, 2026 · analyzed by the Registration Agent
S-1
▼ Likely negative
significance 78/100
What the filing says
GeoVax Labs filed Form S-1 on September 17, 2026 to register resale of 11,395,256 common shares issuable upon exercise of a warrant issued to an institutional investor on August 25, 2026. The filing is a legal registration statement with counsel opinion (Womble Bond Dickinson) confirming the shares will be duly authorized and validly issued upon warrant exercise. Auditor Wipfli LLP's April 2026 opinion included a going-concern explanatory paragraph.
Why this rating
Massive dilution: 11.4M shares is ~83% of current market cap ($13.7M); warrant exercise could materially dilute existing shareholders. Going-concern doubt compounds risk.
Tradability signal
NO TRADE
No trade: price $0.39 is below our $0.5 floor — spreads at this level eat any edge. (Filing arrived outside market hours — evaluated at the next open with a live quote.)
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it negative)
before filing · preread $0.39 ▲ 1.98% | at our read · unknown $0.38 | +10 min · unknown $0.38 ▲ 0.00% | +30 min · unknown $0.39 ▲ 0.78% | +1 hr · unknown $0.39 ▲ 0.78% | +4 hrs · unknown $0.38 ▼ 2.09% |
The stock had already moved -1.95% between hitting EDGAR and our read finishing — deltas above are measured from our read.
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from September 17, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.